Looking to login to start testing? Click Here

One Platform. Five Regions. A Growing Global Network.

WHERE EYEONIC OPERATES

Eyeonic is an Australian-developed, TGA-approved visual field testing platform validated through international peer-reviewed research. We are building active operations, research collaborations, and distribution partnerships across North America, Europe, Southeast Asia, Australia and New Zealand, and India. Select a region below to explore how Eyeonic operates in your market.

Contact Us / Get in Touch

Eyeonic at a glance:

  • 5 Active Regions: United States, European Union, Southeast Asia, Australia and New Zealand, and India — each with dedicated operations, regulatory status, and partnership pathways.
  • TGA Approved (2025): Eyeonic holds Australian Government TGA approval, confirming it meets regulatory standards for therapeutic goods used in clinical environments.
  • India Regulatory Approval (2024): Approved for clinical deployment in India, supporting large-scale rollout across hospital networks and health programmes.
  • 6+ Research Collaborator Nations: Active research partnerships in the United Kingdom, Vietnam, Israel, Brazil, Uganda, South Africa, and New Zealand.
Interactive Map

Where Eyeonic Operates

Hover a region to highlight it. Click to visit the location page.

Hover a highlighted region to explore. Click to visit the location page.

United States

Eyeonic supports North American telehealth providers with FDA-compliant AI visual field testing. No specialist hardware required — accessible on any computer or tablet from any location.

Explore United States

European Union

Eyeonic supports multisite EU clinical trials with standardised, digital visual field testing — eliminating inter-site hardware variability and supporting decentralised trial designs.

Explore European Union

Southeast Asia

Eyeonic is building distribution and research partnerships across ASEAN, with active collaborators in Vietnam and a platform designed for deployment across primary and community care settings.

Explore Southeast Asia

Australia & New Zealand

Proudly Australian. TGA-approved in 2025 and actively collaborating with ANZ ophthalmologists, academic medical centres, and health networks on clinical research and telehealth integration.

Explore ANZ

India

Regulatory approved in India in 2024. Eyeonic is partnering with hospital groups, ophthalmology networks, and health programmes across India to bring scalable AI glaucoma detection to one of the world’s largest eye health markets.

Explore India
Our Valued Partners
Future of Glaucoma Care

Realising the Vision

The shared vision of reducting blindness globally through improved access to critical eyecare diagnosis via digital products is being realised.

Start Today
Call Now Email Us Start Today